KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Accumulated Expenses (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Accumulated Expenses for 17 consecutive years, with $3.3 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 4.16% to $3.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 billion through Dec 2025, down 4.16% year-over-year, with the annual reading at $3.3 billion for FY2025, 4.16% down from the prior year.
  • Accumulated Expenses hit $3.3 billion in Q4 2025 for Bausch Health Companies, down from $3.6 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $5.1 billion in Q2 2021 to a low of $2.9 billion in Q1 2023.
  • Historically, Accumulated Expenses has averaged $3.7 billion across 5 years, with a median of $3.4 billion in 2024.
  • Biggest five-year swings in Accumulated Expenses: increased 18.85% in 2021 and later crashed 41.11% in 2022.
  • Year by year, Accumulated Expenses stood at $4.8 billion in 2021, then crashed by 37.63% to $3.0 billion in 2022, then increased by 4.85% to $3.1 billion in 2023, then grew by 11.36% to $3.5 billion in 2024, then decreased by 4.16% to $3.3 billion in 2025.
  • Business Quant data shows Accumulated Expenses for BHC at $3.3 billion in Q4 2025, $3.6 billion in Q3 2025, and $3.5 billion in Q2 2025.